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Background: The number of elderly patients who undergo surgery for esophageal cancer is increasing as
a result of longer life expectancy, but little is known about the morbidity and outcome of such procedures
in the elderly. This study compared the results of surgery for evaluating the effect of age on esophageal
cancer patients.
Methods: Patients who underwent surgery with curative intent for esophageal cancer from January 1999
to July 2009 were included in this retrospective study. Data were compared between patients 70 years
(elderly group) and patients <70 years old (younger group). Patient characteristics, hospital course,
surgical mortality, morbidity, and survival were compared between patients in these two age groups.
Results: Of the 166 patients included, 35 (21.1%) were at least 70 years old (mean age, 75.2 years) and 131
(78.9%) were younger than 70 years old (mean age, 51.8 years). All 29 eligible elderly and 29 randomly
selected, age-adjusted younger patients were included for a balanced comparison. The elderly group had
signiﬁcantly longer hospital stays (46 vs. 22 days) and a signiﬁcantly higher incidence of surgical
morbidity (51.7% vs. 20.7%). Cardiopulmonary-related complications were the main causes of operative
morbidity in the elderly group. The elderly group also had higher performance state scores. On the basis
of less adjuvant anticancer treatment received, the overall survival of elderly patients was comparable to
their younger counterparts (12.1 vs. 12.7 months; p ¼ 0.77).
Conclusion: The results of this study suggest that curative surgery for esophageal cancer in elderly
patients may result in comparable overall survival and greater, but acceptable, morbidity in comparison
with younger patients. Our data suggest that age 70 years old should not be considered a counter-
indicator for curative surgery in esophageal cancer patients.
Copyright  2010, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Globally, there are about 400,000 new patients with a diagnosis
of esophageal cancer annually.1 Esophageal cancer is the eighth
most common cancer, and the sixth cause of cancer mortality.
Esophageal cancer is a highly lethal disease, with an overall
survival rate of less than 20%.2e4 With the aging of the pop-
ulation and longer life expectancy, diagnosis of esophageal cancer
and surgical treatment in the elderly have become more
frequent.5e7erest.
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n).
iwan Society of Geriatric EmergenFor esophageal cancer, esophagectomy, if applicable, offers the
best palliation of dysphagia and chance for cure.8,9 However, surgical
treatment for esophageal cancer has been considered to be the most
difﬁcult among all kinds of gastrointestinal cancers, because of not
only the biological aggressiveness of the cancer but also the
anatomical characteristics.3 Although the number of elderly patients
with a diagnosis of potentially resectable esophageal cancer is
increasing and the treatment quality is reﬁned along with
improvement of perioperative care, there is still contradictory data
on the indication for surgery in such patients.10e13 Controversies
also exist about the effect of advanced age on the outcome of
esophagectomy.13
Although there is no well-established cutoff to deﬁne a patient as
“elderly” for esophageal surgery, 70 years has been used for assessing
treatmentoutcomeof esophageal cancer patients bymost studies.2,6,9
Surgical treatmentwith curative intent foresophageal cancer involves
extensive procedures, including esophagectomy, lymph nodecy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Comparison of presenting symptoms of patients with esophageal cancer
Presenting symptoms/groups Patients >70 yr Patients <70 yr
(N¼ 29) (N¼ 29)
Dysphagia 25 21
GI bleeding 0 3
Asymptomatic 0 1
Abdominal pain 0 1
Chest pain 2 1
Back pain 2 2
GI ¼ gastrointestinal.
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patients, the ability to tolerate such extensive operation is usually
taken into account. However, little is known about surgicalmorbidity
and outcome in this population.
The objective of this retrospective study was to evaluate the
effect of age on themorbidity andmortality and outcome of surgery
in esophageal cancer patients.
2. Materials and Methods
We retrospectively reviewed the medical charts of patients with
esophageal cancer who underwent surgery with curative intent
between January 1999 and July 2009 in onemedical center. Patients
were divided into elderly (70 years and older) and younger (<70
years old) groups. For a sample size-balanced comparison in this
study, tumor stage-matched younger subjects were randomly
selected as the comparator group. Tumor TNM staging was based
on the AJCC Staging Manual, 6th edition.
Management for each patient with esophageal cancer in our
institution was discussed by a multidisciplinary team. The tran-
shiatal Orringer technique was used for lower esophageal tumors
and transthoracic esophagectomy (Ivor-Lewis or Mckeown proce-
dures) for tumors of the mid and upper third of the esophagus in all
patients. The gastric pull-up techniquewas considered thepreferred
methodof alimentary tract reconstruction. For adequate staging and
survival analysis, patients were excluded if they had received
preoperative chemotherapy and/or radiotherapy or incomplete
resection of the tumor, microscopically or macroscopically. Clinical
data, includingmedical history, tumor characteristics, postoperative
course, and survival, were collected from medical records.
Postdischarge follow-up was conducted every 3 months for the
ﬁrst 2 years and every 6 months thereafter. The workup included
chest roentgenography, chest computed tomography, panendo-
scopy, abdominal sonography, serum levels of carcinoembryonal
antigen, and squamous cell carcinoma antigen, Tc-m99 whole body
bone scan and brain scan or, optionally, whole body positron
emission tomography. Tumor progression or recurrence was diag-
nosed in the presence of biopsy-proven malignancy or positive
ﬁndings on at least two different types of clinical examination as
deﬁned above. Patients who were lost to follow-up after surgery
were excluded in the survival analysis.
The primary endpoint of this study was the outcome of surgery,
including in-hospital morbidity and mortality. The secondary
endpoint was cancer survival. Survival time was calculated from
the date of surgery to the latest follow-up contact or the date of
death. In patients with disease recurrence, salvage therapy was
provided at the discretion of the treating physician.
Statistical analysis was performed using the independent t test
and c2 test or Fisher exact test as appropriate. The Kaplan-Meier
method was used for survival analysis, and survival in the two
groups was compared using the log rank test. The SPSS/PCþ
Advanced Statistics 12.0 software package (SPSS Inc., Chicago, IL,
USA) was used. A difference was considered signiﬁcant if the p
value was less than 0.05.
3. Results
During the study period, 166 patients with esophageal cancer
received esophagectomy with curative intent, of whom 35 (21.1%)
were in elderly group and 131 (78.9%) were in younger group. The
mean age of the entire patient sample was 61.3 years (range, 38e82
years). Among elderly patients, four were lost to follow-up after
surgery and two patients underwent surgery after induction che-
moradiotherapy. Thus, 29 elderly patients were included in the
analysis along with the same number of younger patients.Progressive dysphagia was the most common clinical symptom in
both groups (Table 1). Other than age, there were no signiﬁcant
differences between the two groups in gender, performance
status, or tumor characteristics (Table 2). Because of physician
concerns about poor tolerance, elderly patients received less
intense adjuvant therapy, but this difference was not signiﬁcant.
Elderly patients had signiﬁcantly longer postoperative hospital
stays and greater morbidity. Cardiopulmonary complications
were the major causes of perioperative morbidity (Table 3). There
was higher mortality rate in the elderly than in the younger
group, but this difference was not signiﬁcant.
The mean follow-up time for patients was 14.913.2 months. In
the survival analysis (Figs. 1 and 2), the overall median survival time
was 12.1 months (95% conﬁdence interval, 10.9e13.3 months). There
wasno signiﬁcant difference in survival betweenelderly and younger
patients (12.1 vs. 12.7 months; 95% conﬁdence interval, 8.6e15.6 vs.
11.0e14.4 months). For subgroup analysis of these patients, there are
no signiﬁcantly survival differences for all (Table 4).
4. Discussion
This study compared the outcome of curative surgery between
elderly and younger patients with esophageal cancer. The results
indicate that although the elderly had greater surgical and in-
hospital morbidity, their overall survival was similar. The impact of
age on survival and complications from the surgical procedure in
patients with esophageal cancer are not well delineated.8 Data have
not been sufﬁcient to develop a systematic method for evaluating
the risk of combined modality therapy or primary surgery in the
elderly. Although the decision to operate depends on a number of
factors, our ﬁndings indicate that age 70 years should not be
considered a contraindication for esophagectomy.
There are many factors, such as cancer stage, the use of neo-
adjuvant therapy and adjuvant therapy, and other clinically related
factors, andothers, inﬂuencing the outcome of operative procedures,
including esophagectomy. The most important clinically related
factor is treatment quality of the hospital,which ismainly dependent
on case volume.14 A recent study by Rodgers et al.15 showed that
morbidity and mortality were inversely associated with surgical
volume. Their results suggested that hospitals performing 13
esophagectomies per year were associated with better outcome.
Thus, this factor does not become a critical one in this study.
Complete resection remains the mainstay treatment of choice for
esophageal cancer.1,2,5 In elderly patients, dysfunction of critical
organs, such as pulmonary, cardiac, or renal dysfunction is frequently
associated with this disease.3 This explains why previous studies
suggested age was a risk factor for esophagectomy.6,9,13,16 However,
recent advances in anesthesiological management and perioperative
care have allowed elderly patients with high operative risk to
undergo surgery with postoperative morbidity and mortality rates
comparable to those of younger individuals17. This further supports
our ﬁndings that age should not be considered a contraindication
for curative surgery in esophageal cancer patients.
No. at risk: 
54 10 2 1 
Fig. 1. Survival of patients with surgical treatment of esophageal cancer.
Table 2
Comparison of characteristics of patients undergoing surgery for esophageal cancer
Characteristics Patients >70 yr Patients <70 yr p
(N¼ 29) (N¼ 29)
Genderdno. (%)
Male 22 (75.9) 26 (89.7)
Female 7 (24.1) 3 (10.3) NS
Mean age SDdyr 75.2 3.6 51.8 7.4 <0.001
ECOG performance
statusdno. (%)
0 26 (89.7) 28 (96.6)
1 2 (6.9) 1 (3.4) NS
2 1 (3.4) 0
Mean tumor size SD
(range)dcm
5.59 2.04 5.58 2.16
(3.5e12.0) (2.5e12.0)
0e4.0 6 7
4.1e8.0 21 19 NS
>8.1 2 3
TNM stage of tumordno. (%)
I 0 1 (3.4) NS
II 14 (48.2) 10 (34.5)
III 11 (37.9) 12 (41.4)
IV 4 (13.8) 6 (20.7)
Histologic classiﬁcationdno. (%)
Adenocarcinoma 3 (10.3) 3 (10.3) NS
Squamous cell carcinoma 26 (89.7) 26 (89.7)
Tumor locationdno. (%)
U/3 5 (17.2) 3 (10.3)
M/3 11 (37.9) 3 (10.3) NS
L/3 13 (44.8) 8 (27.6)
Adjuvant therapydno. (%)
With CCRT 16 (55.2) 22 (75.9) 0.10
Without CCRT 13 (44.8) 7 (24.1)
SD¼ standard deviation; ECOG¼ Eastern Cooperative Oncology Group; U/3¼ upper
third; M/3¼middle third; L/3¼ lower third; CCRT¼ concurrent chemo-
radiotherapy; NS¼ no signiﬁcance.
H.-C. Liu et al.178In this study, surgical morbidity in the elderly group was
signiﬁcantly higher than that of younger patients. In contrast, the
mortality rate in patients at least 70 years old was not signiﬁcantly
higher than that of younger patients. Aging is a vague process aboutTable 3
Comparison of surgical treatment results of elderly and nonelderly patients with
nonsmall cell lung cancer
Complications\groups Patients >70 yr Patients <70 yr p
(N¼ 29) (N¼ 29)
Post-OP stay (d) 46 36.8 22 8.8 <0.001
(12e252) (10e41)
Mortalitydno. (%) 3 (10.3) 1 (3.4) NS
Morbiditiesdno. (%) 15 (51.7) 6 (20.9) 0.01
Cardiopulmonary 9 4
Arrythmia 1 1
Respiratory failure 1 1
Pneumonia 8 2
ARDS 2 1
AMI 1 0 <0.001
Heart failure 1 0 NS
GI bleeding 1 1 0.01
Pleural effusion 2 1
Sepsis 4 0
Wound infection 3 3
Anastomotic leak 4 1
Reoperation 3 0
Graft necrosis 1 0
Postoperative bleeding 1 0
Tracheostomy 1 0
Multiple complex complications were found in several patients.
Post-OP¼ postoperative; ARDS¼ adult respiratory distress syndrome; AMI¼ acute
myocardial infarction; GI¼ gastrointestinal; NS¼ no signiﬁcance.physiologically functional decrease. Elderly patients often present
with poor medical and physiological status18,19 and have a higher
prevalence of coexisting cardiopulmonary or cerebrovascular
disease.20 The resulting compromise in pulmonary and
cardiovascular function is therefore of concern when evaluating
surgical risk for the elderly.3,13 Age-related deterioration of
pulmonary function usually does not produce symptoms in
unstressed individuals, but the stress of surgery may result in
reduced respiratory vital capacity and maximum voluntary venti-
lation. The normal physiological reserve that protects against
adverse effects of peri- and postoperative hypoxia and hypercapnea
is also markedly diminished in the elderly.21,22 Collectively, these
factors may contribute to the higher complication rates found in
our elderly patients.
In this study, elderly patients had signiﬁcantly longer post-
operative hospital stays than younger patients. Along with aging,
physiological function of both sympathetic and parasympathetic
nervous system gradually decreases.23,24 This explains whyFig. 2. Kaplan-Meier survival curves between different groups of patients with surgical
treatment for esophageal cancer.
Table 4
Survival analyses of subgroup patients undergoing surgery for esophageal cancer
Characteristics Patients >70 yr Patients <70 yr p
(N¼ 28) (N¼ 26)
Genderdno. (%)
Male 21 (75.0) 23 (88.5) 0.56
Female 7 (25.0) 3 (11.5) 0.89
TNM stage of tumordno. (%)
I 0 1 (3.8) d
II 14 (50.0) 9 (34.6) 0.37
III 11 (39.3) 11 (42.3) 0.50
IV 3 (10.7) 5 (19.2) 0.96
Histologic classiﬁcationdno. (%)
Adenocarcinoma 3 (10.7) 3 (11.5) 0.69
Squamous cell carcinoma 25 (89.3) 23 (88.5) 0.84
Tumor locationdno. (%)
U/3 5 (17.9) 3 (11.5) 0.22
M/3 11 (39.3) 15 (57.7) 0.39
L/3 12 (42.9) 8 (30.8) 0.90
Adjuvant therapydno. (%)
With CCRT 15 (53.6) 20 (76.9) 0.70
Without CCRT 13 (46.4) 6 (23.1) 0.60
U/3¼ upper third; M/3¼middle third; L/3¼ lower third; CCRT¼ concurrent
chemoradiotherapy.
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than it does in younger patients. Aside from the higher incidence of
complications, theremay be other sources of physiologic instability.
When the autonomic nervous system deteriorates somewhat with
aging, impaired autonomic activity may result in poor thermoreg-
ulation in response to stress. During anesthesia, older patients cool
to a greater extent and require a longer period of time for
rewarming.25 Hypothermia may result in increased postoperative
discomfort and predispose the patient to perioperative wound
infection and morbid cardiac events.26,27 There can be no substi-
tute for careful preoperative assessment in the elderly, including
efforts to optimize control of underlying diseases, but intensive
postoperative monitoring and care are stringently recommended.23
Because anoperation canbeperformedsafelydoesnotnecessarily
mean that it should be performed. Sabel et al.7 suggested that the
overall poor prognosis of esophageal carcinoma combined with the
high morbidity of esophagectomy and the short life expectancy of
older patients precludes surgical resection. Although the results of
this study suggest that the morbidity of esophageal resection in
the older population does not carry a signiﬁcantly higher mortality,
the question remains whether there is a survival beneﬁt to make
the procedure worthwhile. Overall median survival in this series
was similar in the elderly and younger age groups (12.1 vs. 12.7
years). Previous studies also found that the improvement in survival
with surgical over nonsurgical management was similar for older
and younger patients.4,7 This ﬁnding was not secondary to adjuvant
therapy because it was less often given in the elderly group.
A number of studies,2,3,5e8 including the present study, have
demonstrated that active therapy in the elderly population provides
comparable beneﬁts to those obtained in their younger counterparts.
The decision to treat or not to treat by surgery always requires the
balancing of treatment risk with beneﬁts. Certainly if the beneﬁt is
expected to be small, onewould be reluctant to subject the patient to
the risks of surgery. However, because the beneﬁtmay be substantial,
chronologic age should not be considered as an absolute contraindi-
cation for esophageal resection.6 Esophageal surgeons should be
aware of the heterogeneity of underlying conditions in elderly
patients and perform a comprehensively individualized assessment
before deciding for or against surgery. This is particularly the case
when considering the options for esophageal surgery. Elderly
patients with esophageal cancer, concerned family members, andmedical professionals are rightly worried about the risks of surgery.
Informed decision making, however, requires that they also have
accurate information about potential beneﬁts.
5. Conclusion
Elderly patients with esophageal cancer who undergo surgery
with curative intent havemore complications and longerhospital stay
than younger patients. However, elderly individuals who recover
from the surgery have similar survival to their younger counterparts.
Therefore, the beneﬁts of surgery for esophageal cancer should not be
withheld from patients simply because of their chronologic age. Both
physicians and elderly patients should consider the differences in
risks but similar beneﬁts for this surgery compared with younger
patients as an essential part of the decision-making process.
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